견적문의

SANTA CLARA, CALIF.--( / )--AttackIQ®, the leading independent vendor of Breach and Attack Simulation (BAS) systems, today announced that Ross Brewer has been promoted to General Manager and Vice President of Europe, Middle East and Africa (EMEA) and Asia Pacific Japan (APJ) regions. In his new role, Brewer will be responsible for developing the strategy to expand AttackIQ’s presence in the regions, including delivering IT security and risk management leaders with solutions to identify gaps in their security posture more effectively and prioritize security initiatives more efficiently.

Brewer brings more than 35 years of sales and management experience with technology organizations across the globe. He previously served as strategic advisor for EMEA at AttackIQ, where he played a pivotal role in shaping the messaging and selling strategies over the last year to deliver strong growth in the financial and insurance services, oil and gas, healthcare, government, higher education, and technology sectors.

Additionally, he helped launch AttackIQ’s Academy in EMEA and APJ to provide advanced cybersecurity training, modularized curriculum, and cyberrange labs to security practitioners free of charge, in these markets. Today, more than 9,000 students in 100 countries across EMEA and APJ are continuing their cybersecurity education with AttackIQ Academy.

“CISOs around the globe recognize the importance of being adequately prepared for breaches, as the cost, complexity and frequency of cybersecurity attacks continues to exponentially increase,” said Carl Wright, Chief Commercial Officer, AttackIQ. “Ross has a proven track record of helping organizations in EMEA and APJ invest strategically in cybersecurity technology, partnerships, and practice enablement. We look forward to continuing to help security and risk leaders validate their investments and gain confidence with a threat-informed defense.”

In addition to large private and public customers throughout EMEA and APJ, including Bupa, BT, and a number of Government Ministries including Finance, Energy, Health and Sovereign Investment funds, AttackIQ has seen significant growth in the Gulf Cooperation Council (GCC) region as governments in countries like The United Arab Emirates, Kingdom of Saudi Arabia, Qatar, Oman, Kuwait and Bahrain look for cybersecurity solutions to protect their digital transformation initiatives.

As part of AttackIQ’s strategic expansion in these regions, the company signed a distribution agreement in November 2020 with Westcon-Comstor, a leading global technology distributor in the EMEA and APAC regions. Today, AttackIQ is building a presence and teams in the United Kingdom, United Arab Emirates, and Kingdom of Saudi Arabia.

“AttackIQ’s strong international growth is a direct result of its industry-leading platform, and I am excited to be joining the executive management team to continue helping organizations in these regions drive toward cybersecurity excellence,” said Brewer. “As recently noted by Gartner, breach and attack simulation is in the list of top security and risk management trends of 2021 due to its ability to help proactively identify and resolve gaps in security postures. The acceleration of c-suite leaders adopting a threat-informed defense and purple team construct with the help of AttackIQ is a direct result of leaders needing a higher level of confidence in their defensive posture.”

About AttackIQ

AttackIQ, the leading independent vendor of breach and attack simulation solutions, built the industry’s first Security Optimization Platform for continuous security control validation and improving security program effectiveness and efficiency. AttackIQ is trusted by leading organizations worldwide to plan security improvements and verify that cyberdefenses work as expected, aligned with the MITRE ATT&CK framework. The Company is committed to giving back to the cybersecurity community through its free AttackIQ Academy, open Preactive Security Exchange, and partnership with the MITRE Engenuity. For more information, visit Follow AttackIQ on Twitter, Facebook, LinkedIn, and YouTube.

View source version on businesswire.com:AttackIQ Appoints New General Manager and Vice President of EMEA and APJ Regions

SAN FRANCISCO--( / )--Vineti, Inc., the leading digital “platform of record” for personalized therapies, today announced a new partnership with Tessa Therapeutics to 누나넷 성인주민등록번호 advance and scale personalized cell therapies for solid 누나넷 무한공유싸이트 tumors in Asia and world-wide.

Tessa Therapeutics (Tessa), an international clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for cancer, is a leading developer of personalized T cell therapies for solid tumors, 누나넷 로또경우의수 including head and neck cancers and cervical cancer. Vineti provides the leading digital software platform to align and manage 유부녀야동판매사이트 Tessa동숭동맞고 complex personalized cell therapy process, safely and efficiently.

The goal 누나넷 윈도우7과xp프린터공유 of the partnership is to scale Tessa’s therapies world-wide in a safe and efficient manner, supporting both late clinical stage therapies approaching commercialization and 누나넷 early-phase therapies progressing through various clinical stages. Tessa, headquartered in Singapore, brings international expertise through both its Asia 동숭동맞고 로또당첨금계산기 operations and its global treatment network.

Tessa’s Virus-Specific T cell (VST) technology is showing compelling results and an excellent safety profile in the treatment 누나넷 로또대박 of cancer. The company is currently conducting a multi-center Phase 누나넷 III 일일툰 Tessa’stargeting nasopharyngeal cancer, and a Phase 누나넷 로또사주 I trial targeting cervical cancer and oropharyngeal cancer, set to move into Phase II in 2019. In addition, Tessa is developing a broad pipeline of pre-clinical therapies targeting major cancers such as liver and lung using its VST platform.

“As a team of industry experts who care deeply about patient care, Tessa understands the current challenges in cell therapy and is addressing them proactively by partnering with Vineti,” said Tessa Chief Business Officer Jennifer Butler. “By running our therapies on the Vineti platform, we 누나넷 로또복권온라인구매 are taking an important step towards global commercial readiness.”

Vineti’s 누나넷 김태희키스신 platform will support 한국에로 Vineti’sas it builds its pipeline of therapies and prepares for commercialization, with a focus on providing a digital orchestration platform to track, trace, align, and simplify the complex journey that underlies 누나넷 로또1등확률 each therapy’s personalized operations and logistics chain. Vineti is now supporting patients and clinicians in more than 65 leading medical centers, and is rapidly expanding to Asia-Pacific and Europe.

“Vineti is honored to support Tessa in its work to develop transformative, critically-needed therapies,” said Vineti 누나넷 ㄹ또 CEO Amy DuRoss. “The Vineti platform is designed to support innovative therapies as they evolve and scale. Therapeutic advances against solid tumors will make a real difference for even more patients, and we 누나넷 번호추출기 are very excited to 동숭동맞고 지하철쩍벌녀 help Tessa scale their treatments 누나넷 로또판매시간 globally.”

Vineti is the first cloud-based software platform to safely and efficiently move patient-based personalized therapies into mainstream medicine at scale. The Vineti platform - configurable, cloud-based, secure and scalable - brings the best of enterprise software to next-generation pharmaceutical science. Vineti’s solution aligns, manages, integrates and simplifies all the major steps and stakeholders in the inherently complex cell and gene 누나넷 꼭지모음 therapy process, helping everyone from health care providers to biopharma and manufacturers exert efficiency and control to 누나넷 연금복권1등후기 optimize the patient’s therapy journey.

This announcement follows Tessa’s recent research collaboration 누나넷 with St. 누나넷 눈썹털 Jude, and Vineti’s strategic teaming agreement with Deloitte.

About 누나넷 대구남자눈썹 수서동홀덤 About누나넷 Therapeutics 동숭동맞고 대구아이라인

Tessa Therapeutics is a clinical stage biopharmaceutical company with the scientific vision of revolutionizing the treatment of cancer by 누나넷 복권번호조회 redirecting the body’s potent anti-viral immune response to recognize and kill cancer cells. Tessa’s virus-specific T cell (VST) platform has shown compelling results in the treatment of solid tumors, and the Company is building a portfolio of therapies addressing a wide range of tumors by combining the qualities of its T cell platform with complementary technologies. Tessa’s lead Phase III trial for nasopharyngeal carcinoma (NPC) is the world’s largest Phase III T cell immunotherapy trial for any cancer indication. The Company is also conducting a Phase I trial targeting cervical cancer and oropharyngeal cancer which is expected to move into Phase II in 2019. In addition, Tessa is developing a broad pipeline of pre-clinical programs targeting major cancers such as liver and lung cancer. The Company has built up robust operational and supply chain capabilities to successfully deliver T cell therapy treatments to a large patient pool across five countries. The combination of technologies from its academic, clinical, and commercial research partners have enabled Tessa to create a fully-integrated approach to the treatment of cancer with immunotherapy. For more information on Tessa, please visit

About 누나넷 우리바카라 Vineti, Inc.

Vineti is the first commercial, configurable cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges patients, medical 누나넷 복권번호추천 providers, biopharmaceutical companies and regulators face in the delivery and commercialization of individualized therapies. The Vineti “platform of record” integrates logistics, manufacturing and clinical data for individualized therapies to align and orchestrate the cell and gene therapy process and improve product performance overall. Caregivers and pharmaceutical pioneers are 누나넷 행운의로또번호 empowered to help more patients more effectively and safely, treatments are better understood and improved over time, and most importantly, there’s an opportunity to provide greater health outcomes?and cures?to patients in need. The company is expanding rapidly, and the Vineti platform is now in use in more than 65 leading medical centers and growing. For more information, please visit Sign up to follow @vinetiworks on

View source version on businesswire.com:Korea Newswire distributes 누나넷 로또당첨금수수료 your news across every media channels through the industry’s 동숭동맞고 오늘의숫자 largest press release distribution network